Recent landmark coronary prevention studies utilizing the statin class of drugs have conclusively demonstrated the benefit of lowering low density lipoprotein cholesterol (LDL-C) in reducing morbidity and mortality from coronary heart disease (CHD).

* Nonfatal MI/CHD death ‡ Primary Prevention

^†Secondary Prevention ** Normal cholesterol levels

The Lancet 1994;344:1383-1389 JAMA 1998:279:1615-1622.

N Engl J Med 1995;333:1301-1307. N Engl J Med 1998;339:1329-1357

N Engl J Med 1996;335:1001-1009